Bronchiectasis and NTM Research Registry

Non-CF Bronchiectasis Clinical Trial

Official title:

Bronchiectasis and NTM Research Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01822834
• Other study ID #: BRR
• Status: Recruiting
• Start date: January 2008
• Est. completion date: December 2050

Study information

• Verified date: March 2022
• Source: COPD Foundation
• Contact: Delia Prieto
• Phone: 1-866-731-2673
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions.

Description:

The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) Bronchiectasis and Nontuberculosis Mycobacteria (NTM) patients from multiple clinical institutions. The goal of the Bronchiectasis Research Registry is to support collaborative research and assist in the planning of multi-center clinical trials for the treatment of NTM and non-CF Bronchiectasis, a progressive, non-curable disease of the lungs, which afflicts thousands of patients. The Registry will also be used to provide better insight into the study of the different types of Bronchiectasis, as well as the pathophysiology of the disorder. In 2012, in collaboration with NTM Info and Research, Inc (NTMir) and the consortium members, the COPD Foundation expanded the Bronchiectasis Research Registry to enroll patients with "non tuberculous mycobacteria (NTM) only". Prior to this time, the registry included individuals with Bronchiectasis, with or without NTM.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 5000
• Est. completion date: December 2050
• Est. primary completion date: December 2050
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 120 Years

Eligibility

Inclusion Criteria:

• Over the age of 18

• non-CF Bronchiectasis

• Nontuberculosis Mycobacteria (NTM)

Exclusion Criteria:

• Under the age of 18

• CF Bronchiectasis

Related Conditions & MeSH terms

• Bronchiectasis
• Non-CF Bronchiectasis
• Nontuberculosis Mycobacteria (NTM)

Locations

Country	Name	City	State
United States	COPD Foundation	Washington	District of Columbia

Sponsors (1)

Lead Sponsor	Collaborator
COPD Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient Recruitment and Data analysis	The COPD Foundation expects to assist at least 4 researchers (with patient recruitment and/or data analysis) annually.	December 2050